Medinice S.A. (ICE.WA)

PLN 7.45

(-0.67%)

EBITDA Summary of Medinice S.A.

Medinice S.A.'s latest annual EBITDA in 2023 was -4.72 Million PLN , down -26.58% from previous year.
Medinice S.A.'s latest quarterly EBITDA in 2024 Q1 was -1.23 Million PLN , down -12.04% from previous quarter.
Medinice S.A. reported an annual EBITDA of -4.63 Million PLN in 2022, down -48.99% from previous year.
Medinice S.A. reported an annual EBITDA of -2.53 Million PLN in 2021, down -13.55% from previous year.
Medinice S.A. reported a quarterly EBITDA of -1.23 Million PLN for 2024 Q1, down -12.04% from previous quarter.
Medinice S.A. reported a quarterly EBITDA of -987 Thousand PLN for 2023 Q1, up 26.18% from previous quarter.

Annual EBITDA Chart of Medinice S.A. (2023 - 2016)

Historical Annual EBITDA of Medinice S.A. (2023 - 2016)

Year	EBITDA	EBITDA Growth
2023	-4.72 Million PLN	-26.58%
2022	-4.63 Million PLN	-48.99%
2021	-2.53 Million PLN	-13.55%
2020	-2.68 Million PLN	-36.48%
2019	-2.12 Million PLN	-10.38%
2018	-1.72 Million PLN	-173.5%
2017	-612.57 Thousand PLN	-106.79%
2016	-296.22 Thousand PLN	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-1.18 Million PLN	2.44%
2024 Q1	-1.23 Million PLN	-12.04%
2023 Q1	-987 Thousand PLN	26.18%
2023 FY	- PLN	-26.58%
2023 Q4	-1.19 Million PLN	-2.22%
2023 Q3	-1.17 Million PLN	10.05%
2023 Q2	-1.3 Million PLN	-32.02%
2022 Q1	-935 Thousand PLN	-218.03%
2022 FY	- PLN	-48.99%
2022 Q4	-1.33 Million PLN	-27.82%
2022 Q3	-1.04 Million PLN	-9.87%
2022 Q2	-952 Thousand PLN	-1.82%
2021 Q4	-294 Thousand PLN	65.69%
2021 Q2	-985 Thousand PLN	-219.81%
2021 Q1	-308 Thousand PLN	79.29%
2021 Q3	-857 Thousand PLN	12.99%
2021 FY	- PLN	-13.55%
2020 Q4	-1.48 Million PLN	-225.99%
2020 Q1	-436.21 Thousand PLN	45.76%
2020 Q2	-42.2 Thousand PLN	90.33%
2020 Q3	-456.31 Thousand PLN	-981.28%
2020 FY	- PLN	-36.48%
2019 Q2	-327.8 Thousand PLN	-40.69%
2019 FY	- PLN	-10.38%
2019 Q4	-804.19 Thousand PLN	-66.03%
2019 Q3	-484.37 Thousand PLN	-47.76%
2019 Q1	-232.99 Thousand PLN	69.17%
2018 Q1	-254.49 Thousand PLN	8.34%
2018 Q4	-755.77 Thousand PLN	-160.58%
2018 Q2	-419.15 Thousand PLN	-64.7%
2018 FY	- PLN	-173.5%
2018 Q3	-290.03 Thousand PLN	30.8%
2017 Q2	-154.87 Thousand PLN	0.0%
2017 FY	- PLN	-106.79%
2017 Q3	-132.9 Thousand PLN	14.19%
2017 Q4	-277.65 Thousand PLN	-108.91%
2016 FY	- PLN	0.0%

Peer EBITDA Comparison of Medinice S.A.

Name	EBITDA	EBITDA Difference
Adiuvo Investments S.A.	-5.08 Million PLN	7.04%
Genomtec S.A.	-7.75 Million PLN	39.054%
Medicalgorithmics S.A.	2.23 Million PLN	311.499%
Synektik Spólka Akcyjna	125.43 Million PLN	103.769%